CSL - Loan Capital

Stock Price
146.76
Daily Change
0.74 0.51%
Monthly
-18.55%
Yearly
-43.68%
Q1 Forecast
150.05

CSL reported $10.69B in Loan Capital for its fiscal semester ending in June of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 103.21K 73.88K Jun/2023
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 398K 204K Sep/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 10.69B 1.37B Jun/2025
Curis USD 29.43M 10.69M Jun/2024
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
TherapeuticsMD USD 0 0 Mar/2022